Phase 1 clinical trial on Orgasmic Meditation (OM): Assessing safety and feasibility as a meditation practice for individuals with PTSD

一项关于性高潮冥想(OM)的I期临床试验:评估其作为创伤后应激障碍(PTSD)患者冥想练习的安全性和可行性。

阅读:2

Abstract

BACKGROUND: We measured the safety and efficacy of a treatment protocol that includes Orgasmic Meditation (OM), a structured attention training practice conducted between two people who follow a predefined set of detailed instructions. The practice involves one person gently stroking the clitoris of the other person for 15 minutes while both place their attention on the point of contact and notice what they feel. Practitioners of OM have reported that this practice is distinct both from typical sexual engagement and other forms of meditation (Siegel et al., 2022). METHODS: Approved by Advarra Pro00061665. The study involved 28 participants (14 pairs), who were recruited based on residence in the Massachusetts area, being in a relationship, and having no history of practicing OM. Twenty-three of these participants identified and scored as having PTSD symptoms (PCL-5 scores >31). Participants were instructed to perform the OM practice a minimum of 12 times over a 4-week period and met weekly with the principal investigator to determine if any safety issues were manifesting. A series of surveys (Daily: Tumescence Survey and OM journal. Baseline and weekly: PCL-5. Baseline, completion and follow up: Eudaimonia assessment, PHQ-9, Gad-7, BIPF, and OM perception survey at) were administered to measure the results. RESULTS: Orgasmic Meditation showed positive results in persons with PTSD. Orgasmic meditation is safe and may offer improvement in symptoms. OM showed 47 % improvement in PTSD scores Average score decreased from 60 to 28. Average score across 23 participants rate 4.9/5 that OM is safe. CONCLUSION: These results suggest that Orgasmic Meditation may be safe for this traumatized population, and may ameliorate symptoms of PTSD. Further research appears to be warranted to determine the efficacy of OM in treatment of PTSD.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。